

(Adds share reaction, background on the company) By Carl O'Donnell and Arno Schuetze Sept 7 (Reuters) - GW Pharmaceuticals Plc, a developer of marijua...


(Adds background, research details, congressman, industry comment) By Doina Chiacu and Bill Berkrot WASHINGTON/NEW YORK, Aug 11 (Reuters) - The U.S. D...


(ShareCast News) - Cannabinoid-focused pharmaceutical company GW Pharmaceuticals posted financial results for the third quarter ended 30 June on Tuesd...


(ShareCast News) - UK economic growth halved in the last three months, according to analysis by a respected independent think tank, which is worse tha...


(ShareCast News) - Developer of cannabinoid therapies GW Pharmaceuticals announced on Wednesday that it intends to sell, subject to market and other c...


** Drug developer GW Pharmaceuticals' shares up 22.8 pct, best day in 3 mths and at 9 mth highs, after saying a late-stage trial of its epilepsy drug...